VERO BIOTECH
Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients with a variety of pulmonary and cardiac diseases. They are currently developing inhaled nitric oxide (NO) products for use in both the hospital setting and for longer-term applications outside of the hospital setting. These products, which are based on our GeNOsyl™ drug delivery technology, are comprised of a single-use drug cassette and either a portable console or wearable controller. Its technology is designed to deliver NO safely for a variety of therapeutic indications and to provide clinicians with a solution that is more user-friendly than currently available NO delivery systems.
VERO BIOTECH
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
2006-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.vero-biotech.com
Total Employee:
101+
Status:
Active
Contact:
3217852460
Total Funding:
234.64 M USD
Technology used in webpage:
OpenResty GoDaddy SSL
Similar Organizations
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
LucasPye BIO
A Contract Development and Manufacturing Organization (CDMO) that manufactures protein-therapeutic and viral-therapeutic drug products.
Pfizer
Pfizer provides access to safe and effective and affordable medicines and health care services.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Advisors List
Board_member
2023-01-11
Current Employees Featured
Brent V. Furse President & Chief Executive Officer @ Vero Biotech
President & Chief Executive Officer
John Maynard VP of New Product Development @ Vero Biotech
VP of New Product Development
2019-06-01
Kurt Dasse Chief Executive Officer @ Vero Biotech
Chief Executive Officer
Investors List
Petrichor Healthcare Capital Management
Petrichor Healthcare Capital Management investment in Venture Round - Vero Biotech
MVM Life Science Partners
MVM Life Science Partners investment in Series E - Vero Biotech
Runway Growth Capital
Runway Growth Capital investment in Debt Financing - Vero Biotech
Official Site Inspections
http://www.vero-biotech.com Semrush global rank: 13.8 M Semrush visits lastest month: 72
- Host name: 114.65.197.35.bc.googleusercontent.com
- IP address: 35.197.65.114
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Vero Biotech"
Vero Biotech - Crunchbase Company Profile & Funding
Vero Biotech is a biopharmaceutical company focused on the design, development, and commercialization of next-generation products to address the unmet medical needs of patients …See details»
VERO Biotech Company Profile | Management and Employees List
VERO Biotech Profile and History. VERO Biotech LLC (formerly known as GeNO LLC) is a biotechnology company focused on the design, development, and commercialization of next …See details»
VERO Biotech Company Profile 2024: Valuation, …
VERO Biotech has raised $356M. Who are VERO Biotech’s investors? Petrichor Healthcare Capital Management , MVM Partners , Horizon Technology Finance BDC , Brace Pharma Capital , and Bain Capital Credit are 5 of 6 investors …See details»
Our Story - VERO Biotech
At VERO Biotech, our mission is to improve the lives of patients by developing innovative technologies for inhaled nitric oxide delivery in the acute care hospital setting and beyond; wherever nitric oxide treatment is needed. We strive to …See details»
Vero Biotech Inc. Company Profile | Austell, GA | Competitors ...
Find company research, competitor information, contact details & financial data for Vero Biotech Inc. of Austell, GA. Get the latest business insights from Dun & Bradstreet.See details»
Vero Biotech - Funding, Financials, Valuation & Investors
In funding over 7 rounds. Their latest funding was raised on Jan 11, 2023 from a Venture - Series Unknown round. Vero Biotech is funded by 3 investors. Petrichor Healthcare Capital …See details»
VERO Biotech Company Profile - Office Locations, Competitors
VERO Biotech (formerly GeNO) is a biotechnology company focused on the design, development, and commercialization of inhaled nitric oxide delivery systems for patients with …See details»
VERO BIOTECH LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VERO BIOTECH LLC of Atlanta, GA. Get the latest business insights from Dun & Bradstreet.See details»
Vero Biotech - Products, Competitors, Financials, Employees ...
Vero Biotech specializes in biotechnology with a focus on inhaled nitric oxide delivery systems for patients with cardiopulmonary conditions. Use the CB Insights Platform to explore Vero …See details»
Vero Biotech | Biotech Careers
Vero Biotech focuses on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with …See details»
Series E - Vero Biotech - 2021-12-21 - Crunchbase
Dec 21, 2021 Organization Name . Vero Biotech . Announced Date Dec 21, 2021; Funding Type Series E; Funding Stage Late Stage Venture; Money Raised . $100M. Lead Investors. Edit …See details»
VERO Biotech Raises $30 Million to Accelerate Commercialization …
Jan 11, 2023 For information, please visit www.vero-biotech.com or contact Ray Russo at [email protected] or (908) 313-7172. Contact for VERO Biotech. Ray Russo Head of Commercial …See details»
How Does Vero Biotech Work? – CANVAS, SWOT, PESTEL & BCG …
Dec 19, 2024 By harnessing the power of biotech, Vero Biotech is redefining how medical treatments are developed, tested, and brought to market. With a focus on improving patient …See details»
Vero Biotech, Inc. (Vero Biotech, Inc.) - 药物管线_专利_临床试验_投 …
Financing led by Petrichor strengthens VERO Biotech's position as a leader in neonatal intensive care ATLANTA, Jan. 11, 2023 /PRNewswire/ -- VERO Biotech Inc., a commercial-stage …See details»
Leadership Team - VERO Biotech
GENOSYL ® is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic …See details»
Vero Biotech - Contacts, Employees, Board Members ... - Crunchbase
Organization. Vero Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
Solutions - VERO Biotech
VERO Biotech actively validates new equipment on an ongoing basis with the GENOSYL ... HOSPITAL/ORGANIZATION. MESSAGE * * indicates required. Contact Info. 387 Nerem …See details»
Home - VERO Biotech
HOSPITAL/ORGANIZATION. MESSAGE * * indicates required. Contact Info. 387 Nerem Street NW Suite 125 Atlanta, Georgia 30313. contactus@vero-biotech.com ... 877-337-4118 . …See details»
Early Release - Short-Lived Neutralizing Antibody Responses to ...
Dec 11, 2024 MPXV infection is considered endemic in areas of central and western Africa, where it causes thousands of cases annually and where a current multicountry outbreak of …See details»
VERO Biotech Recognized as a 2024 AARC Zenith Award Winner
Sep 18, 2024 VERO will receive the prestigious 2024 AARC Zenith Award at the AARC International Respiratory Congress (AARC Congress 2024) taking place November 20-23 in …See details»